1113PDSurvival and prognostic factors of nasopharyngeal cancer patients in non-endemic countries: A large multicentric database analysis

ConclusionsIn non-endemic countries, NPC showed survival figures comparable to endemic areas. Stage, PS, gender and plasmatic EBV DNA turned out to be prognostic factors. These data represent the benchmark in non-endemic setting and the referral for building new prospective trials.Legal entity responsible for the studyFondazione IRCCS Istituto Nazionale Tumori Milano.FundingHas not received any funding.DisclosureP. Bossi: Advisory / Consultancy: AstraZeneca; Advisory / Consultancy: BMS; Advisory / Consultancy: MSD; Advisory / Consultancy: Angelini; Advisory / Consultancy: Merck; Advisory / Consultancy: Voluntis. R. Mesia Nin: Advisory / Consultancy, Speaker Bureau / Expert testimony: Merck; Advisory / Consultancy, Speaker Bureau / Expert testimony: BMS; Advisory / Consultancy, Speaker Bureau / Expert testimony: MSD; Advisory / Consultancy: AstraZeneca; Advisory / Consultancy: Roche; Advisory / Consultancy: Nanobiotix; Advisory / Consultancy: Nanobiotix; Advisory / Consultancy: Nanobiotix. L.F. Licitra: Honoraria (self), Research grant / Funding (institution), Travel / Accommodation / Expenses: BMS; Honoraria (self), Research grant / Funding (institution): EISAI; Honoraria (self), Research grant / Funding (institution), Travel / Accommodation / Expenses: MSD; Honoraria (self), Research grant / Funding (institution), Travel / Accommodation / Expenses: Merck Serono; Honoraria (self), Research grant / Funding (institution): Boehringer; Honoraria (self), Research grant / Funding (...
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research